Hidalgo-Tenorio C, Sabio-Sánchez J M, Linares P J P, Salmerón L M, Ros-Die E, Jiménez-Alonso J
Autoimmune Disease Unit, Internal Medicine Service, University Hospital Virgen de las Nieves, Granada, Spain.
Clin Rheumatol. 2008 Jan;27(1):115-7. doi: 10.1007/s10067-007-0688-9. Epub 2007 Jul 27.
Magic syndrome is a very uncommon disease, and vascular involvement is exceptional; only one case has been reported in the literature associated to a true aortic aneurysm. The treatment of aneurysms recommended in these patients is based on isolated cases and includes corticosteroids, other immunosuppressant drugs, and surgery. We report a case of a patient with Magic syndrome who developed aneurysm at the end of the aorta during treatment with infliximab, corticosteroids, and cyclosporine and who needed endovascular prosthesis implantation. After 12 months, she suffered an aneurysm of the ascending aorta, dilatation of the sinotubular junction, and severe aortic insufficiency, which forced surgery. During this time, the patient finally died.
马吉综合征是一种非常罕见的疾病,血管受累情况极为罕见;文献中仅报道过1例与真正的主动脉瘤相关的病例。这些患者中推荐的动脉瘤治疗方法基于个别病例,包括使用皮质类固醇、其他免疫抑制药物以及手术。我们报告1例马吉综合征患者,该患者在使用英夫利昔单抗、皮质类固醇和环孢素治疗期间,主动脉末端出现动脉瘤,需要植入血管内假体。12个月后,她出现升主动脉瘤、窦管交界扩张和严重主动脉瓣关闭不全,这迫使进行手术。在此期间,患者最终死亡。